Russell Investments Group
FLNA

Russell Investments Group’s Filana Therapeutics FLNA Stock Holding History

Russell Investments Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.86K Sell
2,400
-4,920
-67% -$7.01K ﹤0.01% 4097
2026
Q1 		$12.4K Sell
7,320
-813
-10% -$1.67K ﹤0.01% 3748
2025
Q4 		$16.1K Hold
8,133
– – ﹤0.01% 3687
2025
Q3 		$23.7K Buy
8,133
+2,708
+50% +$6.23K ﹤0.01% 3544
2025
Q2 		$9.82K Sell
5,425
-19,209
-78% -$34.2K ﹤0.01% 3340
2025
Q1 		$37K Buy
24,634
+2,414
+11% +$6.09K ﹤0.01% 2971
2024
Q4 		$52.4K Buy
22,220
+21,850
+5,905% +$384K ﹤0.01% 2812
2024
Q3 		$10.9K Buy
370
+99
+37% +$2.28K ﹤0.01% 3062
2024
Q2 		$3.35K Hold
271
– – ﹤0.01% 3290
2024
Q1 		$5.5K Hold
271
– – ﹤0.01% 2929
2023
Q4 		$6.1K Sell
271
-2
-0.7% -$42 ﹤0.01% 2887
2023
Q3 		$4.54K Buy
273
+85
+45% +$1.69K ﹤0.01% 3160
2023
Q2 		$4.61K Buy
+188
New +$4.53K ﹤0.01% 3124
2023
Q1 		– Sell
-7,295
Closed -$215K – 3373
2022
Q4 		$215K Hold
7,295
– – ﹤0.01% 2553
2022
Q3 		$305K Hold
7,295
– – ﹤0.01% 2419
2022
Q2 		$205K Hold
7,295
– – ﹤0.01% 2535
2022
Q1 		$270K Hold
7,295
– – ﹤0.01% 2395
2021
Q4 		$318K Sell
7,295
-152
-2% -$7.97K ﹤0.01% 2590
2021
Q3 		$461K Sell
7,447
-76,499
-91% -$6.38M ﹤0.01% 2497
2021
Q2 		$7.17M Buy
83,946
+50,979
+155% +$2.73M 0.01% 1122
2021
Q1 		$1.48M Buy
+32,967
New +$1.3M ﹤0.01% 2049

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Russell Investments Group's FLNA Position: Q2 2026 in Review

Russell Investments Group reduced its Filana Therapeutics (FLNA) stake by 67% in Q2 2026, selling an estimated $7.01K and leaving 2,400 shares worth $2.86K. The position accounts for ﹤0.01% of the portfolio, ranked #4097.

Russell Investments Group first reported a position in FLNA in Q1 2021 and has held it in 21 quarters since. The position peaked at $7.17M in Q2 2021. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Russell Investments Group held 2,400 shares of Filana Therapeutics worth $2.86K as of Q2 2026.
  • Russell Investments Group sold 4,920 Filana Therapeutics shares in Q2 2026, an estimated $7.01K.
  • Filana Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #4097 holding.
  • Russell Investments Group first reported a position in Filana Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • Russell Investments Group's Filana Therapeutics position peaked at $7.17M in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.